Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2911-2920 of 10953

Edit search filters
  1. Efficacy in iNPH Shunting (PENS) Trial

    Rochester, MN

  2. A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

    Jacksonville, FL

  4. A Study Providing the Use of Under Desk Elliptical Devices for Promoting Physical Activity Among Employees

    Rochester, MN

  5. A Study of the Effectiveness and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients with Preserved Ejection Fraction

    Rochester, MN

  6. Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers

  7. A Study Evaluating the Safety, Tolerability, Preliminary Drug/Body Interactions and Biological Activity of MYK-461

    Scottsdale/Phoenix, AZ

  8. A Study of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment for Patients with Stage IIIB/IV Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors

  10. A Study of AF-219 in Subjects with Idiopathic Pulmonary Fibrosis with Persistent Cough

    Rochester, MN

.

Mayo Clinic Footer